Description

(Advanced Fat-Loss Peptide for Metabolic Optimization and Body Composition Management)

Targeted Fat Reduction Without Hormonal Side Effects

AOD 9604 (Advanced Obesity Drug) is a fragment of human growth hormone (HGH) scientifically engineered to promote fat metabolism without the undesirable growth-related effects of full-length HGH. This injectable formulation, delivering 40 mg/mL in a 5 mL sterile vial, provides a clinically relevant, concentrated dose intended for subcutaneous injection in protocols designed to support weight loss, fat burning, and metabolic balance.

As a non-hormonal peptide that mimics the lipolytic region of HGH (fragment 176–191), AOD 9604 is not classified as a growth-promoting or anabolic agent. Instead, it is widely utilized in functional and aesthetic medicine for its ability to accelerate fat breakdown, especially in resistant areas such as the abdomen, hips, and thighs.

Key Features

• Concentration: 40 mg/mL

• Volume: 5 mL multidose sterile vial

• Form: Peptide solution for subcutaneous injection

• Storage: Refrigerate between 2–8°C (36–46°F); do not freeze

• Administration: Subcutaneous (most often abdominal or flank region)

• Peptide Classification: Modified HGH fragment 176–191

What Is AOD 9604?

AOD 9604 is a synthetic analog of the C-terminal end of human growth hormone (HGH), specifically amino acids 176–191. Unlike full HGH, it does not activate IGF-1 or influence linear growth or organ size, making it safe for long-term fat-loss protocols without the risks of acromegaly or insulin resistance.

It has been shown in clinical and preclinical studies to:

• Stimulate lipolysis (fat breakdown)

• Inhibit lipogenesis (fat accumulation)

• Enhance weight loss in combination with diet and exercise

• Promote cartilage regeneration and anti-inflammatory benefits

Mechanism of Action

AOD 9604 works by mimicking the fat-burning effects of natural HGH without activating its growth-related receptors. It binds to specific receptors on fat cells (adipocytes) and stimulates:

• cAMP production, activating protein kinase A (PKA)

• Mobilization of stored fat for energy

• Inhibition of fat formation in adipose tissue

• Improved lipid oxidation and metabolic rate

Its targeted action allows reduction of subcutaneous fat stores while preserving lean body mass.

Clinical Applications

AOD 9604 is used off-label under the guidance of licensed healthcare providers for:

• Medical weight management

• Targeted fat loss (especially abdominal and visceral)

• Obesity and metabolic syndrome

• Stubborn fat in peri-menopausal and aging populations

• Support during HRT (Hormone Replacement Therapy)

• Post-weight-loss body composition tuning

It is commonly incorporated into functional medicine, age management, and aesthetic fat-loss protocols.

Dosing and Administration

• Standard dose: 300–600 mcg per day, subcutaneously

• Administration: Daily injection, typically in the abdominal region

• Timing: Best used in the morning or pre-meal to support lipolysis

• Protocol: 8–12 week cycles, often repeated intermittently based on goals

AOD 9604 can be used alone or in combination with other peptides or weight management therapies, including semaglutide, MIC/B12, or exercise-based programs.

Safety and Tolerability

AOD 9604 is considered safe and well-tolerated, with no significant adverse effects noted in clinical trials. Unlike full HGH, it does not elevate blood glucose, insulin, or IGF-1 levels.

Possible side effects (rare and typically mild):

• Injection site redness or irritation

• Temporary headache or fatigue

• Mild bloating or GI discomfort (in rare cases)

No known systemic hormonal disruption has been reported.

Contraindications and Precautions

Contraindicated in:

• Pregnant or breastfeeding individuals

• Patients with active cancer or recent history of malignancy

• Known hypersensitivity to peptide formulations

Use with caution in:

• Individuals with insulin sensitivity disorders

• Patients undergoing active hormonal therapy (monitor interactions)

• Those on calorie-restricted diets (ensure protein intake is sufficient)

Storage and Handling

• Store between 2–8°C (36–46°F)

• Protect from light and moisture

• Do not freeze

• Use within 28–30 days of first puncture

• For subcutaneous use only under professional guidance

Why Choose AOD 9604?

• Highly concentrated formula (40 mg/mL) for precise dosing

• Clinically studied and safe for fat-loss without hormonal side effects

• Compatible with HRT, GLP-1s, and aesthetic protocols

• Ideal for use in functional, sports, and integrative medicine

• No known effect on IGF-1 or long-term endocrine axis

AOD 9604 Injectable Peptide – 40 mg/mL, 5 mL vial provides a targeted, well-tolerated approach to fat metabolism that bypasses the risks associated with traditional hormone-based therapies. Backed by clinical research and increasingly adopted by progressive metabolic medicine practices, AOD 9604 is a key tool in optimizing body composition, energy balance, and metabolic wellness—all without growth-promoting side effects.